ℹ️
🇬🇧
Search
Search for people relevant for "febril neutropenia"
febril neutropenia
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Tomáš Skácel Ph.D.
External person at First Faculty of Medicine
11 publications
Publications
publication
Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis – The Neulasta versus Current Neutropenia Management Practice (Neucup) Project
Publication without faculty affiliation
publication
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
2021 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Pokroky a současné možnosti v léčbě mnohočetného myelomu
2021 |
First Faculty of Medicine
publication
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
2019 |
Central Library of Charles University, Faculty of Medicine in Hradec Králové
publication
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma
2018 |
First Faculty of Medicine
publication
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
2018 |
First Faculty of Medicine
publication
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis
2011 |
First Faculty of Medicine
publication
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study
2006 |
First Faculty of Medicine
publication
Achieving Full-Dose, On-Schedule Administration of ACE Chemotherapy Every 14 Days for the Treatment of Patients with Extensive Small-Cell Lung Cancer
2006 |
First Faculty of Medicine
publication
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study
2006 |
Faculty of Physical Education and Sport
Load more publications (1)
Loading network view...